HBM Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HBMHF research report →
About the company
HBM Holdings Limited is a biopharmaceutical company in the clinical development phase, dedicated to the discovery and advancement of differentiated antibody therapeutics for immunological and oncological disorders. The firm's robust pipeline includes several notable candidates: Batoclimab (HBM9161), a human monoclonal antibody designed to selectively bind to and inhibit the neonatal fragment crystallizable receptor; Tanfanercept (HBM9036), intended to address moderate to severe dry eye disease; HBM7008, a bispecific antibody engineered to engage tumor-associated antigens; and HBM4003, a human anti-CTLA-4 antibody directed against cytotoxic T-lymphocyte-associated antigen-4. Furthermore, HBM is advancing HBM9022 as a treatment for SARS-COV-2, HBM9302 for breast and gastric cancers, and HBM7020 for multiple myeloma.
- CEO
- Jingsong Wang
- IPO
- 2022
- Employees
- 183
- HQ
- Shanghai, CN
Price Chart
- Market Cap
- $1.30B
- P/E
- 21.85
- P/S
- 11.36
- P/B
- 3.30
- EV/EBITDA
- 18.62
- Div Yield
- 0.00%
- Gross Margin
- 92.85%
- Op Margin
- 43.28%
- Net Margin
- 51.67%
- ROE
- 17.09%
- ROIC
- 9.67%
- Revenue
- $158.21M · 315.25%
- Net Income
- $91.47M · 3192.59%
- EPS
- $0.12 · 3233.33%
- Op Income
- $80.70M
- FCF YoY
- 128.58%
- 52W High
- $2.54
- 52W Low
- $1.10
- 50D MA
- $1.56
- 200D MA
- $2.05
- Beta
- 1.35
- Avg Volume
- 226.384
Get TickerSpark's AI analysis on HBMHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HBMHF coverage
Recent articles, reports, and earnings notes.
No research on HBMHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HBMHF report →Similar companies
Peers in the same neighborhood.